about
α-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8The Impact of Immunosenescence on Pulmonary DiseaseAspergillus Species in Bronchiectasis: Challenges in the Cystic Fibrosis and Non-cystic Fibrosis Airways.Sensitization to Aspergillus species is associated with frequent exacerbations in severe asthma.Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infectionsAntibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungimiR-126 is downregulated in cystic fibrosis airway epithelial cells and regulates TOM1 expression.It is all in the sputum: a case of non-resolving pneumonia.Pulmonary proteases in the cystic fibrosis lung induce interleukin 8 expression from bronchial epithelial cells via a heme/meprin/epidermal growth factor receptor/Toll-like receptor pathway.Sister Mary Joseph noduleAlpha-1 proteinase inhibitors for the treatment of alpha-1 antitrypsin deficiency: safety, tolerability, and patient outcomes.Isolated anterior mediastinal tuberculosis in an immunocompetent patient.Treatment of multiple-level tracheobronchial stenosis secondary to endobronchial tuberculosis using bronchoscopic balloon dilatation with topical mitomycin-C.Aspergillus-associated airway disease, inflammation, and the innate immune responseDiagnosis and management of asthma in older adults.Candida species in cystic fibrosis: A road less travelled.Effect of estrogen on pseudomonas mucoidy and exacerbations in cystic fibrosis.Advances in the diagnosis and management of asthma in older adults.Fungi in the cystic fibrosis lung: bystanders or pathogens?Immunoevasive Aspergillus virulence factors.Transforming growth factor β and severe asthma: a perfect storm.Long-term future risk of severe exacerbations: Distinct 5-year trajectories of problematic asthma.Microbiomes in respiratory health and disease: An Asia-Pacific perspective.Understanding COPD-overlap syndromes.Regulation of cystic fibrosis transmembrane conductance regulator by microRNA-145, -223, and -494 is altered in ΔF508 cystic fibrosis airway epithelium.The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD.Pleural fluid analysis: standstill or a work in progress?Male fertility in cystic fibrosis.Air quality impacts mortality in acute medical admissions.Disabling disease codes predict worse outcomes for acute medical admissions.Blood basophil activation is a reliable biomarker of allergic bronchopulmonary aspergillosis in cystic fibrosis.17Beta-estradiol inhibits IL-8 in cystic fibrosis by up-regulating secretory leucoprotease inhibitor.Trimethoprim-sulfamethoxazole induced acute interstitial nephritis in renal allografts; clinical course and outcome.Recurring pulmonary hamartomas: cause for concern?Aspergillus/allergic bronchopulmonary aspergillosis in an Irish cystic fibrosis population: a diagnostically challenging entity.Immune, inflammatory and infectious consequences of estrogen in women with cystic fibrosis.Blood cultures in emergency medical admissions: a key patient cohort.Optimisation of dementia management in Irish primary care.Chitinase activation in patients with fungus-associated cystic fibrosis lung disease.The basophil surface marker CD203c identifies Aspergillus species sensitization in patients with cystic fibrosis.
P50
Q24633462-B65CDE4C-D8B0-43FE-A80F-C06EAF58071EQ26801157-A369CADD-CAAE-4B00-A502-0EFDCC82FFCCQ30234423-0FCF5ECB-865C-4673-BD73-FD3934200250Q33609986-61A56B90-5223-431F-ADBF-3C4BC2E6214AQ33786154-ED99EEF8-AF27-4025-ABD2-0FB0EF30A41CQ33792765-DB0FE8D6-E34E-45AF-AC67-E53A08726A15Q34093492-C2048E4F-6CF6-400F-8A9D-04C0A7A7E407Q34573527-1C31AEAF-47BF-4B55-8D89-47003B72D327Q34606483-835B49EE-4B56-4496-B745-4E8F022E6123Q34904577-01B54660-9C01-40F6-A9C0-D8B862AA6FE8Q35063726-54729FAE-B71C-43F0-A028-0357D7DF2045Q35913975-0852B51E-8728-4F57-8BC9-2A8267D11E68Q35990618-34216412-29C0-422E-86F7-0DE269C032C5Q37077782-CE61FECC-84EC-409C-96F7-7B9BD7C0AD2FQ37502960-1D37819A-EDCA-4BF3-9025-7360C3B9DE9EQ37808468-93C4F9BC-C076-45C7-AE34-CFA9467D8E3DQ38011211-97373EBA-EBBE-4F8C-A12B-AF30ED9BDEDBQ38174964-CC1864F0-FA00-4340-BF7E-2BEFF410D49DQ38195680-9D56377C-A28E-4DDF-9CF3-15FFAC5E4386Q38223924-40BB5695-2AD4-40B0-91BC-F14D4995253FQ38252852-B4CBD0D0-4351-4EC0-A1F5-25D4BC38F4D5Q38745124-BFB8DE7A-074E-4528-9C2D-763184776A3DQ39095070-80F92DB6-AD46-4001-B871-FACC1F714598Q39173255-E55F22CA-42E8-4AA1-A289-DD063AB94935Q39189253-BA9B3119-F203-4541-9262-F213A0E134E6Q39200222-1B2079AB-63FA-4E37-B22B-E42163E78472Q39636689-FA198F92-CA2D-4443-A1A7-06546CF78814Q39945074-8720B554-78AF-4376-88D2-4F2A0F39389FQ40158885-6C2E7BF5-CDF9-4502-BA3C-90006896CD6EQ40181654-06FB2B2D-BADB-467F-A962-034A256F609CQ40903453-09D73D33-8B34-4E48-A074-9C4708CC47F3Q43105666-8EB18AD6-CE02-4FB8-B03A-8D35AF89C217Q43253357-6BC2B02C-5002-4F91-B265-DBB140EA047BQ43448457-B635708A-CB5F-4F61-838D-E5FC737E7388Q44225024-53E179DF-D1B4-4EB2-891F-48EFA0DA633EQ44381085-BAD81254-0A9F-4EF2-9221-781B03D38902Q44752112-C3663442-9A9E-417F-BCAC-33D5062AE7CBQ44799700-E018BAB7-0DCE-44B0-AC17-6B5F488183BDQ46567407-5E3DCF9F-E6B7-4E74-B48E-EF808AE26AD4Q46666847-844D5D4C-3F20-4872-97EB-026E7CF9A48F
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Sanjay H Chotirmall
@nl
Sanjay H Chotirmall
@sl
Sanjay H. Chotirmall
@en
Sanjay H. Chotirmall
@es
type
label
Sanjay H Chotirmall
@nl
Sanjay H Chotirmall
@sl
Sanjay H. Chotirmall
@en
Sanjay H. Chotirmall
@es
prefLabel
Sanjay H Chotirmall
@nl
Sanjay H Chotirmall
@sl
Sanjay H. Chotirmall
@en
Sanjay H. Chotirmall
@es
P1053
K-4127-2015
P106
P1153
15757175700
P21
P214
7675156012418649700003
P31
P3829
P496
0000-0003-0417-7607
P5008
P7859
viaf-7675156012418649700003